These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 33185161)

  • 1. Oxazolidinone-containing Hybrids with Antibacterial Activity against Methicillin-resistant Staphylococcus aureus (MRSA): A Mini-review.
    Jiang D; Liu B; Gao T
    Curr Top Med Chem; 2021; 21(27):2440-2454. PubMed ID: 33185161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection.
    Gordon O; Dikeman DA; Ortines RV; Wang Y; Youn C; Mumtaz M; Orlando N; Zhang J; Patel AM; Gough E; Kaushik A; Nuermberger EL; Upton AM; Fotouhi N; Miller LS; Archer NK
    Microbiol Spectr; 2022 Oct; 10(5):e0245121. PubMed ID: 36106881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.
    Oh SH; Kim J; Baek SY; Chae SE; Park HS; Cho YL; Kwak JH
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28273820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Activity of Tedizolid, a Novel Oxazolidinone Against Methicillin-Resistant
    Hasannejad-Bibalan M; Mojtahedi A; Biglari H; Halaji M; Sedigh Ebrahim-Saraie H
    Microb Drug Resist; 2019 Nov; 25(9):1330-1337. PubMed ID: 31290721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacodynamics of torezolid phosphate (TR-701), a new oxazolidinone antibiotic, against methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains in a mouse thigh infection model.
    Louie A; Liu W; Kulawy R; Drusano GL
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3453-60. PubMed ID: 21502615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents.
    Siddiqui AM; Sattigeri JA; Javed K; Shafi S; Shamim M; Singhal S; Malik ZM
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1198-1206. PubMed ID: 29525219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of novel oxazolidinone analogs and 13 conventional antimicrobial agents against clinical isolates of Staphylococcus aureus in Beijing, China.
    Lei H; Jiang Y; Wang D; Gong P; Li Y; Dong Y; Dong M
    Jpn J Infect Dis; 2014; 67(5):402-4. PubMed ID: 25241696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700).
    Locke JB; Hilgers M; Shaw KJ
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5265-74. PubMed ID: 19752277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of new oxazolidin-2-one analogues in methicillin-resistant Staphylococcus aureus strains.
    Córdova-Guerrero J; Hernández-Guevara E; Ramírez-Zatarain S; Núñez-Bautista M; Ochoa-Terán A; Muñiz-Salazar R; Montes-Ávila J; López-Angulo G; Paniagua-Michel A; Torres GA
    Int J Mol Sci; 2014 Mar; 15(4):5277-91. PubMed ID: 24675696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
    Hilliard JJ; Fernandez J; Melton J; Macielag MJ; Goldschmidt R; Bush K; Abbanat D
    Antimicrob Agents Chemother; 2009 May; 53(5):2028-33. PubMed ID: 19273686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antibacterial activity of MRX-I, a new oxazolidinone.
    Li CR; Zhai QQ; Wang XK; Hu XX; Li GQ; Zhang WX; Pang J; Lu X; Yuan H; Gordeev MF; Chen LT; Yang XY; You XF
    Antimicrob Agents Chemother; 2014; 58(4):2418-21. PubMed ID: 24395231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of linezolid and tedizolid against clinical isolates of methicillin-resistant and methicillin and linezolid resistant Staphylococcus aureus: an in vitro comparison.
    Peñuelas M; Candel FJ; Lejarraga C; López-González L; Viñuela-Prieto JM; López de Mendoza D
    Rev Esp Quimioter; 2016 Oct; 29(5):255-8. PubMed ID: 27374726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple and Efficient Synthesis of 3-Aryl-2-oxazolidinone Scaffolds Enabling Increased Potency toward Biofilms.
    Ndukwe ARN; Hawas S; Qin J; Wiedbrauk S; Totsika M; Boase NRB; Fairfull-Smith KE
    Mol Pharm; 2023 Jul; 20(7):3484-3493. PubMed ID: 37289102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tedizolid: a new oxazolidinone antimicrobial.
    Kisgen JJ; Mansour H; Unger NR; Childs LM
    Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of linezolid in 16 infants and children in Japan.
    Shinjoh M; Iketani O; Watanabe K; Shimojima N; Kudo M; Yamagishi H; Shimada H; Sugita K; Takahashi T; Mori T; Hasegawa N; Iwata S
    J Infect Chemother; 2012 Aug; 18(4):591-6. PubMed ID: 22460827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.
    Schmidt S; Sabarinath SN; Barbour A; Abbanat D; Manitpisitkul P; Sha S; Derendorf H
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5039-45. PubMed ID: 19786607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction.
    Ji C; Lin W; Moraski GC; Thanassi JA; Pucci MJ; Franzblau SG; Möllmann U; Miller MJ
    Bioorg Med Chem; 2012 Jun; 20(11):3422-8. PubMed ID: 22560837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WCK 4034: A promising oxazolidinone for treating gram positive infections.
    Bhawsar S; Pawar S; Deshpande P; Yeole R; Chavan R; Nandanwar M; Bhagwat S; Patel M
    Bioorg Med Chem Lett; 2022 Sep; 71():128842. PubMed ID: 35680102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and microbiological efficacy of tedizolid (TR-700) against Gram-positive clinical isolates from a phase 2 study of oral tedizolid phosphate (TR-701) in patients with complicated skin and skin structure infections.
    Prokocimer P; Bien P; Deanda C; Pillar CM; Bartizal K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4608-13. PubMed ID: 22687509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.